Department of Health and Human Services March 10, 2008 – Federal Register Recent Federal Regulation Documents
Results 1 - 18 of 18
National Toxicology Program (NTP); Report on Carcinogens (RoC); Request for Public Comments on the RoC Expert Panel's Recommendations on Listing Status for Captafol and Ortho-nitrotoluene in the 12th RoC and the Scientific Justifications for the Recommendations
The RoC Office invites public comment on the recommendations from an expert panel on listing status for captafol and ortho- nitrotoluene in the 12th RoC and the scientific justification for the recommendations. The recommendation and scientific justification for each candidate substance are available electronically in Part B of the Expert Panel Report https://ntp.niehs.nih.gov/go/29682, (see Expert Panel Report Part B) or in printed text from the RoC Office (see FOR FURTHER INFORMATION CONTACT below). The RoC Office convened a nine- member expert panel of scientists from the public and private sectors on October 15-16, 2007. The panel was asked (1) to apply the RoC listing criteria to the relevant scientific evidence and make a recommendation regarding listing status (i.e., known to be a human carcinogen, reasonably anticipated to be a human carcinogen, or not to list) for captafol and for ortho-nitrotoluene in the 12th RoC and (2) to provide the scientific justification for the recommendation.
National Institute for Occupational Safety and Health; Decision To Evaluate a Petition To Designate a Class of Employees at the Savannah River Site, Aiken, SC, To Be Included in the Special Exposure Cohort
The Department of Health and Human Services (HHS) gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees at the Savannah River Site, Aiken, South Carolina, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows: Facility: Savannah River Site. Location: Aiken, South Carolina. Job Titles and/or Job Duties: All workers. Period of Employment: January 1, 1950 through December 31, 2007.
National Institute for Occupational Safety and Health; Decision To Evaluate a Petition To Designate a Class of Employees at the Savannah River Site, Aiken, SC, To Be Included in the Special Exposure Cohort
The Department of Health and Human Services (HHS) gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees at the Savannah River Site, Aiken, South Carolina, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows: Facility: Savannah River Site. Location: Aiken, South Carolina. Job Titles and/or Job Duties: All laborers, foremen, and construction workers. Period of Employment: March 9, 1951 through October 24, 1986.
Notice of Public Meeting: Seeking Comments on Implementation of the NIH Public Access Policy
With this notice, the National Institutes of Health (NIH) of the U.S. Department of Health and Human Services (HHS) announces the following public meeting and seeks public comment regarding implementation of the NIH Revised Policy on Enhancing Public Access to Archived Publications Resulting From NIH-Funded Research. The policy and supporting materials can be found at https://publicaccess.nih.gov. Comments may be submitted in advance of the meeting to NIH Public Access staff at https://publicaccess.nih.gov/comments/comments.htm. All comments for consideration at the meeting must be received on or before March 17, 2008. In addition, NIH advises that it will publish in the Federal Register in March 2008 a notice of availability of a Request for Information (RFI) asking for comments about its Public Access Policy (Policy) and the effectiveness of the Policy's implementation. Public Meeting Time and Date: 10 a.m.-4:30 p.m., Thursday, March 20, 2008.
Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor; Ferric Oxide Injection; Gleptoferron Injection; Iron Dextran Complex Injection; Iron Hydrogenated Dextran Injection
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for two new animal drug applications (NADAs) for injectable iron supplements used in baby pigs from Boehringer Ingelheim Vetmedica, Inc., to Animal Health Pharmaceuticals, LLC. In addition, FDA is taking this opportunity to consolidate injectable iron supplements in a single section of the Code of Federal Regulations (CFR). This is being done to simplify and clarify the regulations.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
